Cerebral bypass grafts may develop generalized graft narrowing or focal stenosis during the perioperative period or later. Endovascular techniques such as PTA and stent placement of graft vessels are potential treatment options. Our objective was to review the safety, indications, technique, and results of endovascular management of graft problems.
C
erebral revascularization with bypass grafts is an important tool in the treatment of complex cerebral aneurysms, cerebral ischemia, and skull base tumors. Autologous graft vessels such as RAGs or SVGs are used to perform ECIC bypasses or IC-IC bypasses. A small number of these bypass grafts may develop problems of poor flow due to vasospasm during the perioperative period (Ͻ30 days) and/or focal segmental stenosis during the late follow-up period. This article studies the use of endovascular interventions in the management of bypass graft problems-both immediate and long term.
Materials and Methods
All patients who underwent cerebral bypass procedures by using graft vessels from January 2005 to December 2009 were identified for an institutional review boardϪapproved prospective cerebrovascular registry. Medical charts were retrospectively reviewed for patient characteristics, bypass procedures, the presence of graft narrowing, indications for endovascular interventions, postprocedure patency, and clinical outcomes. Graft patency was studied from IADSA or CT angiography before and after the endovascular procedure and during follow-up care. In case of late stenosis, endovascular treatment was generally chosen when the stenosis was present in the extracranial segment of the graft. Surgical corrections were performed when the stenosis was present in the intradural portion of the graft or when the extracranial stenosis extended for a significant length of the graft. The surgical technique used in 1 patient (illustrative case 1) was previously reported.
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Results
A total of 99 patients underwent 125 cerebral revascularization procedures for the treatment of aneurysms (n ϭ 80), ischemia (n ϭ 31), and tumors (n ϭ 14). Seventy-nine bypasses were performed by using graft vessels, which included 59 RAGs, 18 SVGs, and 2 tibial arteries. The mean follow-up period of graft bypasses was 29 months. Of this group of 79 bypasses by using graft vessels, 4 grafts developed severe vasospasm (all RAGs) during the perioperative period and 8 grafts (7 RAGs and 1 SVG) developed focal segmental stenosis (Ն50%) during the late follow-up period. All 4 grafts that developed perioperative vasospasm and 3 of the 8 grafts that developed stenosis during the late follow-up period were treated with endovascular intervention. The remaining 5 grafts with late stenosis were managed with surgical repair (n ϭ 4, three RAGs and 1 SVG) and periodic monitoring (n ϭ 1, one RAG). Of the 4 grafts that underwent primary surgical correction, 3 had intracranial graft stenosis and 1 had nonfocal stenosis, present in a considerable portion of the extracranial segment.
The PTA procedures performed in the perioperative period were all immediately successful in improving the flow through the graft, as evident in the completion angiograms. During the follow-up period, 2 (1 VA-to-PCA RAG for ischemia and 1 MCA-to-PCA RAG bypass for aneurysm clipping) of the 4 grafts were occluded with enlargement of collateral vessels. The other 2 bypasses (an ECA-to-MCA RAG bypass for Moyamoya disease and an ICA-to-MCA RAG bypass for aneurysm clipping) remained patent at 18 and 48 months follow-ups.
Three of the 7 patients who were treated with endovascular interventions underwent the procedure during the late follow-up period for symptomatic or severe focal stenosis. Endovascular interventions in the late stenosis group included PTA alone (n ϭ 2) and PTA followed by stent placement in the stenotic graft (n ϭ 1). All 3 procedures were successful immediately in improving the flow through the graft. Two of the patients who underwent only PTA developed recurrent symptoms due to restenosis, while there was no evidence of restenosis in the patient who had PTA and stent placement, as noted at 6 months' follow-up with MR angiography. The recurrent stenoses were surgically repaired by interposition graft placement after resection of the stenoses and a jump graft bypass procedure.
Technique
All PTA procedures were performed with standard transfemoral arterial access. Intravenous heparin titrated to an activated clotting time of 250 -300 seconds was used for systemic anticoagulation in PTA procedures performed in the first 2 weeks postbypass surgery. In cases of late graft stenoses, patients were placed on aspirin (325 mg once daily) and/or clopidogrel for at least 3 days before the procedure in addition to the heparin used during the procedure. After diagnostic angiography, parent vessel catheterization was performed with a 6F guiding catheter. Following this, an Excelsior SL-10 microcatheter (Boston Scientific, Natick, Massachusetts) with a 0.014-inch Synchro microguidewire (Boston Scientific) was used to catheterize the graft vessel. The catheters were inserted beyond the site of stenosis/narrowing, and angiography was performed through the guide catheter to visualize the rest of the graft. A compliant 4 ϫ 10 mm HyperGlide balloon catheter (ev3, Irvine, California) was used for performing the dilation in most procedures. In cases of resistant stenoses, semicompliant Gateway (Boston Scientific) or Monorail Maverick (Boston Scientific) balloons were used for PTA. In perioperative patients, multiple sequential balloon dilations were performed along the entire length of the graft vessel, proceeding from distal to proximal. In focal/segmental stenosis, the PTA procedure was limited to the narrowed region of the graft. In 1 patient, a Neuroform stent (Boston Scientific) was deployed in the proximal part of the RAG bypass from the ECA to the MCA.
The balloons were gradually inflated under close visual inspection to avoid overdilation and rupture of the stenotic vessel. Special care was taken to avoid hyperinflation when using the compliant HyperGlide balloons.
There were no complications during or immediately after the endovascular interventions. There was 1 instance of an unsuccessful catheterization in a patient while attempting a repeat angioplasty procedure for a restenosis. The inability to catheterize the graft was due to a narrowing proximal to the stenosis, where a synthetic graft patch was used to repair graft injury caused by multiple arterial line insertions before harvesting the graft.
Illustrative Case 1 (Patient 1)
A 72-year-old woman presented with subarachnoid hemorrhage from a ruptured basilar tip aneurysm, which was treated by endovascular coiling. Due to coil compaction and recurrence of the aneurysm (21 ϫ 19 ϫ 25 mm), microsurgical clipping was planned. Intraoperatively, due to an inability to clip the aneurysm without occluding the PCA, an IC-IC bypass from the right M2 segment of the MCA to the P2 segment of the PCA was performed to enable clipping. Postoperative angiography showed excellent flow through the graft with complete occlusion of the aneurysm, and the patient recovered well from surgery ( Fig 1A) . However, on postoperative day 2, the patient was noted to be worse than her preoperative condition, with somnolence and mild hemiparesis. An angiogram showed a narrowed graft with decreased flow, for which endovascular salvage was planned (Fig 1B) . With the patient under general anesthesia and 0.035-inch guidewire access, a 6F Envoy guiding catheter (Cordis, Miami Lakes, Florida) was used for catheterization of the right ICA. A 4 ϫ 10 mm HyperGlide balloon was advanced over a 0.10 Expedion guidewire (ev3) into the graft (Fig 1C) . Multiple inflations of the balloon were performed to dilate the vessel at areas of narrowing. Angiograms after the procedures showed notable improvement in the flow through the graft (Fig 1D) . However, there was mild narrowing in the proximal and distal portions of the graft, but further angioplasty was not attempted because of much-improved flow. At 3 months postsurgery, graft flow was sluggish. The graft was found completely occluded on IADSA obtained at 18 months, with filling of the right PCA from an enlarged right PCA (not shown). At 4-year follow-up, she is independent for activities of daily living with some gait ataxia, similar to her preoperative baseline (mRS 2).
Illustrative Case 2 (Patient 6)
A 47-year-old man presented with a subarachnoid hemorrhage from a giant left MCA aneurysm. The aneurysm was microsurgically clipped, leaving a remnant of the neck to preserve flow through distal MCA branches, which were originating from the aneurysm. The patient recovered during the following months but had significant problems with cognition, memory, and judgment. Cerebral angiography revealed a significant stenosis of the superior and major M2 branch of the MCA with significant flow compromise (Fig 2A) . A singlephoton emission CT scan revealed a flow abnormality in the distribution of the superior branch of the MCA. Because no superficial temporal artery was available, a RAG bypass was performed from the ECA to the M2 branch of the MCA on the left side (Fig 2B) . Eight months later, the patient developed symptoms of episodic and significant headaches along with a return of memory problems. On IADSA, the graft was homogeneously narrowed, with an irregular stenosis near the origin and proximal segment (Fig 2C) . He was placed on aspirin, clopidogrel, and lovastatin and underwent endovascular intervention 3 days later. An Excelsior SL-10 preshaped 45°mi-crocatheter with a Synchro-14 guidewire combination was used to access the left ECA-MCA RAG for subselective injection angiography. Then, a HyperGlide balloon catheter and an Expedion-10 guidewire combination was used to access the radial RGA, and sequential balloon dilation was performed of the proximal third to half of the RGA. Last, a Monorail Maverick 3.0 ϫ 20 mm balloon catheter was used to dilate 2 persistent stenoses in the proximal third of the RGA. Following this, a Neuroform stent 4.5 ϫ30 mm was deployed in the proximal portion of the graft (Fig 2D) . The stenosis was corrected, and there was marked improvement in the flow through the graft as noted in the completion angiograms (Fig 2E) . At 3-month follow-up angiography, his graft was patent with good flow (Fig 2F) , also confirmed by an MR angiography at 6 months (not shown). At 9 months' clinical follow-up after the repair procedure, the patient remains free of any symptoms (mRS 0).
Discussion
Endovascular interventions such as PTA and stent placement are commonly used in the treatment of stenoses in coronary and cerebral vasculature. PTA is also used in the treatment of cerebral vasospasm following subarachnoid hemorrhage. The use of such techniques in bypass grafts may logically be considered high-risk, given the presence of surgical anastomosis and possible graft inflammation immediately following a bypass procedure. Endovascular treatment of bypass grafts with high success rates has been described in the coronary circulation. [2] [3] [4] The incidence of vasospasm in bypass grafts has significantly decreased with the use of the pressure distention technique. 5 Sekhar et al, 5 in 2001, reported 2 cases of ECIC RAG vasospasm treated with angioplasty: One was successful, and the other ruptured during the procedure. Since that initial report, the technology of endovascular devices and catheters has advanced significantly and 1 other successful salvage of a bypass graft with PTA has been reported. 6 In this series of patients, there were no complications of endovascular interventions.
In the immediate postprocedural period, all PTA procedures were successful in relieving vasospasm and improving graft flow. During the medium-to-late follow-up period, focal or segmental stenosis of high-flow grafts is generally due to intimal hyperplasia. By extrapolating the evidence from the management of similar pathology in the coronary vasculature, it is logical to expect stent procedures to be more effective than PTA alone in treating the late ECIC graft stenoses. 4, [7] [8] [9] [10] [11] Supporting this hypothesis, both patients who were treated with PTA alone for late RAG stenosis had recurrences after 3 and 5 months (patients 5 and 7). On the other hand, PTA with deployment of a stent in a stenotic RAG (in 1 patient) was effective, as noted with a 6-month follow-up (illustrative case 1). Long-term follow-up after stent placement, however, is needed because the occurrence of in-stent restenosis is not infrequent with the use of bare metal stents.
Any attempt to repair the graft either surgically or endovascularly should be reserved for progressive stenosis, highgrade stenosis (Ͼ50%), or symptomatic stenosis. The possibility of spontaneous resolution of minimal graft stenosis, especially with good control of risk factors such as hypertension and hyperlipidemia, should be considered. Endovascular interventions in this group were limited to late stenoses occurring in the extracranial segments of the graft, whereas surgical corrections were performed for intracranial graft stenoses. In severely stenotic vessels, when there is genuine difficulty in accessing the graft vessel lumen, it may be prudent to abort the procedure and defer to surgical treatment options. Surgical repair is also advised for any stenosis refractory to endovascular intervention or when the stenosis is nonfocal and present in a considerable portion of the graft. Review of this series of patients adds evidence to the safety and role of endovascular interventions both in alleviation of graft spasm in the perioperative period and for the management of stenosis during late follow-up.
Conclusions
Endovascular techniques such as PTA and stent placement are safe to perform in ECIC bypass graft vessels in the extracranial segment of the graft. In the perioperative period, PTA of extracranial segments of the graft is safe and effective in improving poor graft flow. For focal stenoses of the grafts occurring during the follow-up period, PTA alone may only provide a temporary respite, whereas PTA along with stent placement seems to be an effective option. 
